Mid-Day Market Update: Nasdaq Drops 100 Points; Bloom Energy Shares Jump
The Nasdaq turned lower during the mid-day session, with the tech-laden index falling 100 points on Friday. Midway through trading Friday, the Dow traded up 0.30% to 35,348.00 while the NASDAQ fell 0.74% to 14,081.23. The SP also rose, gaining, 0.01% to 4,504.20. Check out this: Executives Sell Around $44M Of 5 Stocks Leading and Lagging Sectors Energy shares climbed 1.8% on Friday. Meanwhile, top gainers in the sector included NGL Energy Partners LP (NYSE: NGL ), up 11% and Precision Drilling Corporation (NYSE: PDS ) up 11%. In trading on Friday, information technology shares tumbled by 0.6%. Top Headline Under Armour, Inc. (NYSE: UAA ) reported better-than-expected earnings for its fourth quarter. Under Armour reported quarterly earnings of $0.14 per share, beating analysts estimates of $0.07 per share. The companys quarterly sales came in at $1.50 billion, versus expectations of $1.48 billion. Equities Trading UP Orphazyme A|S (NASDAQ: ORPH ) shares shot up 18% to $2.4100 as the company issued an update for planned NDA resubmission for arimoclomol for the treatment of Niemann-Pick disease type C in the United States.
Mid-Day Market Update: Nasdaq Drops 100 Points; Bloom Energy Shares Jump
The Nasdaq turned lower during the mid-day session, with the tech-laden index falling 100 points on Friday. Midway through trading Friday, the Dow traded up 0.30% to 35,348.00 while the NASDAQ fell 0.74% to 14,081.23. The SP also rose, gaining, 0.01% to 4,504.20. Check out this: Executives Sell Around $44M Of 5 Stocks Leading and Lagging Sectors Energy shares climbed 1.8% on Friday. Meanwhile, top gainers in the sector included NGL Energy Partners LP (NYSE: NGL ), up 11% and Precision Drilling Corporation (NYSE: PDS ) up 11%. In trading on Friday, information technology shares tumbled by 0.6%. Top Headline Under Armour, Inc. (NYSE: UAA ) reported better-than-expected earnings for its fourth quarter. Under Armour reported quarterly earnings of $0.14 per share, beating analysts estimates of $0.07 per share. The companys quarterly sales came in at $1.50 billion, versus expectations of $1.48 billion. Equities Trading UP Orphazyme A|S (NASDAQ: ORPH ) shares shot up 18% to $2.4100 as the company issued an update for planned NDA resubmission for arimoclomol for the treatment of Niemann-Pick disease type C in the United States.